Eli Lilly teams up with Nvidia on AI lab: CFO explains why
unknown📝 Article Content
Eli Lilly (LLY) is teaming up with Nvidia (NVDA) to invest in an artificial intelligence (AI) innovation lab. Eli Lilly CFO and executive vice president Lucas Montarce joins Market Catalysts host Julie Hyman to discuss how the pharmaceutical company is leveraging AI to expedite drug discovery. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.
📄 Summary
Eli Lilly (LLY) is teaming up with Nvidia (NVDA) to invest in an artificial intelligence (AI) innovation lab. Eli Lilly CFO and executive vice president Lucas Montarce joins Market Catalysts host Julie Hyman to discuss how the pharmaceutical company is leveraging AI to expedite drug discovery. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.